SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: Suma who wrote (22605)11/25/2005 1:32:26 PM
From: gcrispin  Respond to of 78753
 
I posted an article on the VASC board that points out the negatives the company faces in the future.

Message 21796678



To: Suma who wrote (22605)11/27/2005 5:48:45 AM
From: bruwin  Respond to of 78753
 
If we look at the last 5 Annual Results of VASC, we see a company that hasn't made a cent of Bottom Line profit.
However, those losses seem to be reducing as Turnover appears to be increasing.
In addition, its last two Quarterly Results have positive Bottom Lines, so maybe the tide is turning for VASC.
For one thing, it has virtually no long term debt, which cannot be said for many other companies in its line of business, and that should augur well if interest rates continue to rise in the USA.



To: Suma who wrote (22605)12/17/2005 12:15:33 PM
From: CapitalistHogg™  Read Replies (2) | Respond to of 78753
 
VASC is showing up on my event based algorithm, which means it is a potential 'story' stock...are you aware of any events in the near term future that could have an immediate impact on its market cap? Do they have any products up for FDA advisory recommendation or FDA approval?

chris